Is AN2 Therapeutics Inc (ANTX) overvalued? · $32.0M cap
AN2 Therapeutics Inc (ANTX) is a biotechnology company listed on US.
This page asks whether AN2 Therapeutics Inc (ANTX) looks expensive on cached numbers — not a short thesis.
No cached income statement for ANTX, so there is no earnings base to call rich or cheap.
ANTX currently screens at market cap $32.0M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next ANTX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the ANTX stock page for the full model, not this heading.
Not investment advice.